Biohaven Ltd (BHVN)
38.33
-0.66
(-1.69%)
USD |
NYSE |
Apr 22, 16:00
38.66
+0.33
(+0.86%)
Pre-Market: 20:00
Biohaven Total Liabilities (Quarterly): 85.24M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.24M |
| September 30, 2023 | 92.73M |
| June 30, 2023 | 119.48M |
| March 31, 2023 | 146.26M |
| Date | Value |
|---|---|
| December 31, 2022 | 123.01M |
| September 30, 2022 | 35.43M |
| June 30, 2022 | 70.58M |
| December 31, 2021 | 47.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
35.43M
Minimum
Sep 2022
146.26M
Maximum
Mar 2023
90.01M
Average
88.98M
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 53.14B |
| Amgen Inc | 90.92B |
| Regeneron Pharmaceuticals Inc | 7.107B |
| Scholar Rock Holding Corp | 85.82M |
| Alnylam Pharmaceuticals Inc | 4.051B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 513.21M |
| Shareholders Equity (Quarterly) | 427.98M |